Ramsay healthcare annual profit falls

Company News

by Rachael Jones

Ramsay Healthcare (ASX:RHC) has reported its statutory NPAT is down 21 per cent to $388.3 million on last year’s figure $488.9 million.

In good news for the company, its revenue strengthened throughout the year up 5.4 per cent to $9.2 billion.

And its EBITDA is up 6.2 per cent to $1.4 billion.

Results were impacted by a downturn in NHS volumes in their UK business as well as softer growth rates in Australia business and the decision to temporarily slow down the rollout of the Ramsay Pharmacy franchise.

Final dividend is 86.5 cents fully franked, up 6.1 per cent on the previous corresponding period, bringing the full-year dividends to 144.0 cents fully franked, up 7.1 per cent.

Shares in Ramsay Healthcare (ASX:RHC) closed 2.07 per cent higher to $58.16 yesterday.

Rachael Jones

Finance News Network
Rachael comes to FNN after working for Fairfax Media covering international breaking news, including the global economy and politics. She joined FNN in February 2018. She has reported on Australia’s finance news for various organisations since 2000 and has also interviewed a number of key business players, including Bill Gates. Rachael has also worked across a number of countries, including the UK and the US.